Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
Authors:
- Miki InoueMIMiki Inoue
- Naoki KusunoseNKNaoki Kusunose
- Keisuke KakimotoKKKeisuke Kakimoto
- Kengo HamamuraKHKengo Hamamura
- Yuichi HanadaYHYuichi Hanada
- Ayumi ToiATAyumi Toi
- Yuji YoshiyamaYYYuji Yoshiyama
- Fuyuki SatoFSFuyuki Sato
- Katsumi FujimotoKFKatsumi Fujimoto
- Satoru KoyanagiSKSatoru Koyanagi
- Shigehiro OhdoSOShigehiro Ohdo
- 1 May 2012
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 81 (5) , 739-747
Abstract
Differentiated embryo chondrocyte-2 (DEC2), also known as bHLHE41 or Sharp1, is a pleiotropic transcription repressor that controls the expression of genes involved in cellular differentiation, hypoxia responses, apoptosis, and circadian rhythm regulation. Although a previous study demonstrated that DEC2 participates in the circadian control of hepatic metabolism by regulating the expression of cytochrome P450, the molecular mechanism is not fully understood. We reported previously that brief exposure of HepG2 cells to 50% serum resulted in 24-h oscillation in the expression of CYP3A4 as well as circadian clock genes. In this study, we found that the expression of CYP2D6, a major drug-metabolizing enzyme in humans, also exhibited a significant oscillation in serum-shocked HepG2 cells. DEC2 interacted with CCAAT/enhancer-binding protein (C/EBPα), accompanied by formation of a complex with histone deacetylase-1, which suppressed the transcriptional activity of C/EBPα to induce the expression of CYP2D6. The oscillation in the protein levels of DEC2 in serum-shocked HepG2 cells was nearly antiphase to that in the mRNA levels of CYP2D6. Transfection of cells with small interfering RNA against DEC2 decreased the amplitude of CYP2D6 mRNA oscillation in serum-shocked cells. These results suggest that DEC2 periodically represses the promoter activity of CYP2D6, resulting in its circadian expression in serum-shocked cells. DEC2 seems to constitute a molecular link through which output components from the circadian clock are associated with the time-dependent expression of hepatic drug-metabolizing enzyme.Keywords
This publication has 47 references indexed in Scilit:
- Retinoids activate RXR/CAR-mediated pathway and induce CYP3ABiochemical Pharmacology, 2010
- SHARP1/DEC2 inhibits adipogenic differentiation by regulating the activity of C/EBPEMBO Reports, 2008
- System-level identification of transcriptional circuits underlying mammalian circadian clocksNature Genetics, 2005
- Rhythmic expression of DEC1 and DEC2 in peripheral tissues: DEC2 is a potent suppressor for hepatic cytochrome P450s opposing DBPGenes to Cells, 2004
- Coordination of circadian timing in mammalsNature, 2002
- The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian OscillatorCell, 2002
- Molecular Cloning and Characterization of DEC2, a New Member of Basic Helix-Loop-Helix ProteinsBiochemical and Biophysical Research Communications, 2001
- Re‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cellsFEBS Letters, 1998
- Role of the CLOCK Protein in the Mammalian Circadian MechanismScience, 1998
- Polymorphic Drug OxidationCNS Drugs, 1996